These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 2545579

  • 1. [Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
    Oda M, Ino Y, Suzuki K, Sato T, Iwamoto S, Iwaki M.
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):225-34. PubMed ID: 2545579
    [Abstract] [Full Text] [Related]

  • 2. [Antihypertensive effect of repeated oral administration of MK-0521 in 2-kidney Goldblatt hypertensive dogs].
    Oda M, Suzuki K, Ino Y, Sato T, Iwaki M.
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):235-43. PubMed ID: 2545580
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between the inhibition of renin-angiotensin system and antihypertensive effect of MK-421 and captopril in 2-kidney, 1-clip renal hypertensive rats after single and repeated oral administration of MK-421 or captopril].
    Ohmura I, Maki E, Naruse T, Ikeda N, Asami T, Sagawa N.
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):303-13. PubMed ID: 3002926
    [Abstract] [Full Text] [Related]

  • 4. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS, Arbegast PT, Gaul SL, Blaine EH, Gross DM.
    Eur J Pharmacol; 1981 Dec 03; 76(2-3):167-76. PubMed ID: 6174351
    [Abstract] [Full Text] [Related]

  • 5. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM, Sweet CS, Ulm EH, Backlund EP, Morris AA, Weitz D, Bohn DL, Wenger HC, Vassil TC, Stone CA.
    J Pharmacol Exp Ther; 1981 Mar 03; 216(3):552-7. PubMed ID: 6259322
    [Abstract] [Full Text] [Related]

  • 6. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW, Wang FL, Fung WC, Grover GJ, Harvey CM, Scalese RJ, Mitch SL, DeForrest JM.
    Br J Clin Pharmacol; 1989 Mar 03; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K, Minato H, Fukuya F, Kawahara S, Hosoki K, Kadokawa T.
    Arzneimittelforschung; 1985 Mar 03; 35(10):1502-7. PubMed ID: 3000389
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J, Koga T, Yamazaki T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1988 Mar 03; 292():203-22. PubMed ID: 3293542
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological comparison of captopril and MK-422 by a new method for measuring activity of angiotensin converting enzyme (ACE).
    Hidaka H, Sawada S, Sato R, Oka H, Yasuda Y.
    Jpn Circ J; 1985 Nov 03; 49(11):1175-9. PubMed ID: 3005681
    [Abstract] [Full Text] [Related]

  • 10. ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
    Malini PL, Strocchi E, Valtancoli G, Ambrosioni E.
    J Clin Pharmacol; 1990 May 03; 30(5):422-4. PubMed ID: 2161435
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS.
    Fed Proc; 1983 Feb 03; 42(2):167-70. PubMed ID: 6295819
    [Abstract] [Full Text] [Related]

  • 12. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
    Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ.
    N Engl J Med; 1998 Oct 29; 339(18):1285-92. PubMed ID: 9791144
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities.
    Kubo M, Kato J, Ochiai T, Ishida R.
    Jpn J Pharmacol; 1990 Jun 29; 53(2):201-10. PubMed ID: 2200918
    [Abstract] [Full Text] [Related]

  • 14. [Inhibitory effect of N-alpha-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro].
    Ino Y, Oda M, Sato T, Iwaki M.
    Nihon Yakurigaku Zasshi; 1989 Apr 29; 93(4):219-24. PubMed ID: 2545578
    [Abstract] [Full Text] [Related]

  • 15. Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
    Saito H, Nakamaru M, Rakugi H, Mikami H, Ogihara T, Inagami T.
    Clin Exp Pharmacol Physiol; 1990 Nov 29; 17(11):745-53. PubMed ID: 2150362
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).
    Brown NL, Badel MY, Benzoni F, Zanirato J, Vincent JC, Fichelle J, Worcel M.
    Eur J Pharmacol; 1988 Mar 22; 148(1):79-91. PubMed ID: 3383998
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T, Becker FT, Sybertz EJ.
    Life Sci; 1983 Mar 21; 32(12):1297-303. PubMed ID: 6300578
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM, Knappenberger RC, Antonaccio MJ, Ferrone RA, Creekmore JS.
    Am J Cardiol; 1982 Apr 21; 49(6):1515-7. PubMed ID: 6280481
    [Abstract] [Full Text] [Related]

  • 19. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS, Ronsberg MA, Cervoni P.
    Fed Proc; 1984 Apr 21; 43(5):1346-50. PubMed ID: 6200364
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
    Sybertz EJ, Baum T, Ahn HS, Nelson S, Eynon E, Desiderio DM, Pula K, Becker F, Sabin C, Moran R, Vander Vliet G, Kastner B, Smith E.
    J Cardiovasc Pharmacol; 1983 Apr 21; 5(4):643-54. PubMed ID: 6193364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.